>A small, struggling MA biotech gets unsolicited buyout offer for approx 300% above current trading at time...<
And if that highly unlikely scenario occurred here, we'd be at the magnificent figure of 0.39 PPS.
For new buyers coming in at this level- and I think that there are many- things might work out great. But IMHO there are no more good scenarios for long-term holders, only those that contain either more or less pain.